UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo

Nature communications, 2019-05, Vol.10 (1), p.2098-2098, Article 2098

2019

Volltextzugriff (PDF)

Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins

Nature communications, 2019-01, Vol.10 (1), p.45-15, Article 45

2019

Volltextzugriff (PDF)

Genetic in vivo engineering of human T lymphocytes in mouse models

Nature protocols, 2021-07, Vol.16 (7), p.3210-3240

2021

Volltextzugriff (PDF)

Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9991

2021

Volltextzugriff (PDF)

Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication

Hepatology (Baltimore, Md.), 2017-12, Vol.66 (6), p.1750-1765

2017

Volltextzugriff (PDF)

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma

Journal of experimental & clinical cancer research, 2024-09, Vol.43 (1), p.262-18, Article 262

2024

Volltextzugriff (PDF)

A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process

eLife, 2021-06, Vol.10

2021

Volltextzugriff (PDF)

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

PLoS pathogens, 2020-11, Vol.16 (11), p.e1008593-e1008593

2020

Volltextzugriff (PDF)

Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes

Hepatology (Baltimore, Md.), 2019-05, Vol.69 (5), p.2214-2231

2019

Volltextzugriff (PDF)

Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction

Viruses, 2020-12, Vol.12 (12), p.1427

2020

Volltextzugriff (PDF)

Towards Physiologically and Tightly Regulated Vectored Antibody Therapies

Cancers, 2020-04, Vol.12 (4), p.962

2020

Volltextzugriff (PDF)

A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism

PLoS pathogens, 2018-03, Vol.14 (3), p.e1006908-e1006908

2018

Volltextzugriff (PDF)

Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production

JHEP reports, 2021-10, Vol.3 (5), p.100330-100330, Article 100330

2021

Volltextzugriff (PDF)

Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells

Frontiers in genome editing, 2021-02, Vol.3, p.604371-604371

2021

Volltextzugriff (PDF)

Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and future

Joint, bone, spine : revue du rhumatisme, 2021-07, Vol.88 (4), p.105164-105164, Article 105164

2021

Volltextzugriff (PDF)

A Synthetic Circuit Empowering Reprogrammed B Cells for Therapeutic Proteins Expression Regulated by Tumor Detection

Journal of immunotherapy (1997), 2024-09, Vol.47 (7), p.233-238

2024

Volltextzugriff (PDF)

Farnesoid X receptor‐α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo

The FASEB journal, 2019-02, Vol.33 (2), p.2472-2483

2019

Volltextzugriff (PDF)

Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs

Blood, 2014-08, Vol.124 (8), p.1221-1231

2014

Volltextzugriff (PDF)

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Cancer Immunology, Immunotherapy, 2022-07, Vol.71 (7), p.1771-1775

2022

Volltextzugriff (PDF)

Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection

Proceedings of the National Academy of Sciences - PNAS, 2024-04, Vol.121 (16), p.e2314426121

2024

Volltextzugriff (PDF)

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Scientific reports, 2018-03, Vol.8 (1), p.5390-11, Article 5390

2018

Volltextzugriff (PDF)

Engineering B cells with customized therapeutic responses using a synthetic circuit

Molecular therapy. Nucleic acids, 2023-09, Vol.33, p.1-14

2023

Volltextzugriff (PDF)

Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector

Antiviral research, 2017-09, Vol.145, p.14-19

2017

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo

Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins

Genetic in vivo engineering of human T lymphocytes in mouse models

Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors

Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma

A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes

Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction

Towards Physiologically and Tightly Regulated Vectored Antibody Therapies

A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism

Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production

Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells

Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and future

A Synthetic Circuit Empowering Reprogrammed B Cells for Therapeutic Proteins Expression Regulated by Tumor Detection

Farnesoid X receptor‐α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies

Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Engineering B cells with customized therapeutic responses using a synthetic circuit

Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms

Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector

Suchergebnisse filtern